,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
147,GO_Biological_Process_2017b,negative regulation of metanephric mesenchymal cell migration (GO:2000590),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
137,GO_Biological_Process_2017b,positive regulation of dendrite development (GO:1900006),2/62,0.0031571877933943,0.0767264508619422,0,0,26.550666666666668,152.8806924349947,CAMK1D;MAGI2
138,GO_Biological_Process_2017b,positive regulation of axonogenesis (GO:0050772),2/71,0.0041180454204615,0.0767264508619422,0,0,23.07710144927536,126.74813293504668,CAMK1D;MAGI2
139,GO_Biological_Process_2017b,negative regulation of distal tip cell migration (GO:1903355),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
140,GO_Biological_Process_2017b,negative regulation of mesenchymal stem cell migration (GO:1905321),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
141,GO_Biological_Process_2017b,negative regulation of neuroblast migration (GO:0061855),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
142,GO_Biological_Process_2017b,neuromast deposition (GO:0048885),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
143,GO_Biological_Process_2017b,negative regulation of hematopoietic stem cell migration (GO:2000472),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
144,GO_Biological_Process_2017b,negative regulation of cell migration in other organism (GO:0044622),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
145,GO_Biological_Process_2017b,negative regulation of formation of radial glial scaffolds (GO:0061925),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
146,GO_Biological_Process_2017b,negative regulation of glial cell migration (GO:1903976),2/77,0.0048247783322074,0.0767264508619422,0,0,21.224533333333333,113.21145888587664,MAGI2;SRGAP3
136,GO_Biological_Process_2017b,positive regulation of neuron projection regeneration (GO:0070572),2/50,0.0020657293545543,0.0767264508619422,0,0,33.208333333333336,205.3029465636782,CAMK1D;MAGI2
148,GO_Biological_Process_2017b,negative regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905311),2/78,0.0049476409672789,0.0767264508619422,0,0,20.94421052631579,111.18955451927388,MAGI2;SRGAP3
159,GO_Biological_Process_2017b,"negative regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904236)",2/87,0.0061177236567661,0.0767264508619422,0,0,18.718117647058826,95.39810706861432,MAGI2;SRGAP3
158,GO_Biological_Process_2017b,negative regulation of smooth muscle cell migration (GO:0014912),2/86,0.0059820427012735,0.0767264508619422,0,0,18.94190476190476,96.96348130198568,MAGI2;SRGAP3
157,GO_Biological_Process_2017b,"negative regulation of wound healing, spreading of epidermal cells (GO:1903690)",2/86,0.0059820427012735,0.0767264508619422,0,0,18.94190476190476,96.96348130198568,MAGI2;SRGAP3
156,GO_Biological_Process_2017b,negative regulation of fibroblast migration (GO:0010764),2/85,0.0058477708784832,0.0767264508619422,0,0,19.1710843373494,98.57186343548736,MAGI2;SRGAP3
155,GO_Biological_Process_2017b,negative regulation of trophoblast cell migration (GO:1901164),2/82,0.0054534478882884,0.0767264508619422,0,0,19.893,103.67251333208752,MAGI2;SRGAP3
154,GO_Biological_Process_2017b,negative regulation of leukocyte migration (GO:0002686),2/81,0.0053248503141454,0.0767264508619422,0,0,20.145822784810125,105.47084988777765,MAGI2;SRGAP3
153,GO_Biological_Process_2017b,negative regulation of endothelial cell chemotaxis to vascular endothelial growth factor (GO:1904858),2/80,0.0051976807690521,0.0767264508619422,0,0,20.405128205128204,107.3216442944126,MAGI2;SRGAP3
152,GO_Biological_Process_2017b,negative regulation of chemokine activity (GO:1900137),2/80,0.0051976807690521,0.0767264508619422,0,0,20.405128205128204,107.3216442944126,MAGI2;SRGAP3
151,GO_Biological_Process_2017b,negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848),2/80,0.0051976807690521,0.0767264508619422,0,0,20.405128205128204,107.3216442944126,MAGI2;SRGAP3
150,GO_Biological_Process_2017b,negative regulation of muscle cell chemotaxis toward tendon cell (GO:2001282),2/79,0.0050719430509961,0.0767264508619422,0,0,20.67116883116883,109.2271029053093,MAGI2;SRGAP3
149,GO_Biological_Process_2017b,negative regulation of fibroblast chemotaxis (GO:1905211),2/79,0.0050719430509961,0.0767264508619422,0,0,20.67116883116883,109.2271029053093,MAGI2;SRGAP3
160,GO_Biological_Process_2017b,positive regulation of neuron projection development (GO:0010976),2/91,0.0066744637372348,0.0789214372808685,0,0,17.87325842696629,89.53548785071649,CAMK1D;MAGI2
161,GO_Biological_Process_2017b,negative regulation of neuron migration (GO:2001223),2/92,0.0068171341172843,0.0789214372808685,0,0,17.67377777777778,88.16239046381622,MAGI2;SRGAP3
162,GO_Biological_Process_2017b,negative regulation of epithelial cell migration (GO:0010633),2/95,0.0072534505141677,0.0808625409172029,0,0,17.101075268817205,84.2446507080431,MAGI2;SRGAP3
0,GO_Biological_Process_2018,positive regulation of cell projection organization (GO:0031346),2/63,0.0032579962101204,0.0838495478690083,0,0,26.11409836065574,149.54611680407334,CAMK1D;MAGI2
16,GO_Biological_Process_2018,nerve growth factor signaling pathway (GO:0038180),1/10,0.0134211618656948,0.0838495478690083,0,0,85.31623931623932,367.7917019980768,MAGI2
5,GO_Biological_Process_2018,protein deglutamylation (GO:0035608),1/7,0.0094131205361766,0.0838495478690083,0,0,127.99358974358974,597.1733894173036,AGBL4
6,GO_Biological_Process_2018,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,0.0094131205361766,0.0838495478690083,0,0,127.99358974358974,597.1733894173036,DLGAP5
7,GO_Biological_Process_2018,positive regulation of mitotic sister chromatid separation (GO:1901970),1/7,0.0094131205361766,0.0838495478690083,0,0,127.99358974358974,597.1733894173036,DLGAP5
8,GO_Biological_Process_2018,glomerular epithelial cell development (GO:0072310),1/8,0.0107508728609495,0.0838495478690083,0,0,109.7032967032967,497.25962914000377,MAGI2
9,GO_Biological_Process_2018,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/8,0.0107508728609495,0.0838495478690083,0,0,109.7032967032967,497.25962914000377,DLGAP5
10,GO_Biological_Process_2018,glomerular visceral epithelial cell development (GO:0072015),1/8,0.0107508728609495,0.0838495478690083,0,0,109.7032967032967,497.25962914000377,MAGI2
11,GO_Biological_Process_2018,positive regulation of respiratory burst (GO:0060267),1/8,0.0107508728609495,0.0838495478690083,0,0,109.7032967032967,497.25962914000377,CAMK1D
12,GO_Biological_Process_2018,regulation of neuron projection development (GO:0010975),2/119,0.011181364808743,0.0838495478690083,0,0,13.576752136752138,61.00722727167953,CAMK1D;MAGI2
13,GO_Biological_Process_2018,negative regulation of cell migration (GO:0030336),2/121,0.0115428797508124,0.0838495478690083,0,0,13.347226890756302,59.55114208300969,MAGI2;SRGAP3
14,GO_Biological_Process_2018,negative regulation of activin receptor signaling pathway (GO:0032926),1/9,0.0120868859385031,0.0838495478690083,0,0,95.98557692307692,423.8371981703313,MAGI2
27,GO_Biological_Process_2018,establishment of protein localization to endoplasmic reticulum (GO:0072599),1/15,0.020066558464378,0.0838495478690083,0,0,54.832417582417584,214.3235039145759,SRP54
15,GO_Biological_Process_2018,regulation of respiratory burst (GO:0060263),1/10,0.0134211618656948,0.0838495478690083,0,0,85.31623931623932,367.7917019980768,CAMK1D
3,GO_Biological_Process_2018,positive regulation of neuron differentiation (GO:0045666),2/98,0.0077021469594706,0.0838495478690083,0,0,16.564166666666665,80.60547812798312,CAMK1D;MAGI2
17,GO_Biological_Process_2018,nucleoside metabolic process (GO:0009116),1/10,0.0134211618656948,0.0838495478690083,0,0,85.31623931623932,367.7917019980768,MACROD1
18,GO_Biological_Process_2018,intracellular protein transmembrane transport (GO:0065002),1/11,0.014753702756032,0.0838495478690083,0,0,76.78076923076924,323.7277777065472,SRP54
19,GO_Biological_Process_2018,cellular response to growth factor stimulus (GO:0071363),2/139,0.0150238543897624,0.0838495478690083,0,0,11.583065693430656,48.62705397732546,WWOX;MAGI2
20,GO_Biological_Process_2018,glomerular visceral epithelial cell differentiation (GO:0072112),1/13,0.0174135879176465,0.0838495478690083,0,0,63.9775641025641,259.14140891073174,MAGI2
21,GO_Biological_Process_2018,regulation of granulocyte chemotaxis (GO:0071622),1/13,0.0174135879176465,0.0838495478690083,0,0,63.9775641025641,259.14140891073174,CAMK1D
22,GO_Biological_Process_2018,regulation of activin receptor signaling pathway (GO:0032925),1/14,0.0187409364492418,0.0838495478690083,0,0,59.05325443786983,234.8574522333829,MAGI2
23,GO_Biological_Process_2018,mitotic cell cycle arrest (GO:0071850),1/14,0.0187409364492418,0.0838495478690083,0,0,59.05325443786983,234.8574522333829,MAGI2
24,GO_Biological_Process_2018,positive regulation of CREB transcription factor activity (GO:0032793),1/15,0.020066558464378,0.0838495478690083,0,0,54.832417582417584,214.3235039145759,CAMK1D
25,GO_Biological_Process_2018,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,0.020066558464378,0.0838495478690083,0,0,54.832417582417584,214.3235039145759,DLGAP5
2,GO_Biological_Process_2018,positive regulation of neuron projection development (GO:0010976),2/97,0.0075512120775495,0.0838495478690083,0,0,16.73936842105263,81.78934401151223,CAMK1D;MAGI2
1,GO_Biological_Process_2018,negative regulation of cell motility (GO:2000146),2/97,0.0075512120775495,0.0838495478690083,0,0,16.73936842105263,81.78934401151223,MAGI2;SRGAP3
26,GO_Biological_Process_2018,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,0.020066558464378,0.0838495478690083,0,0,54.832417582417584,214.3235039145759,MAGI2
4,GO_Biological_Process_2018,"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",1/6,0.0080736268908127,0.0838495478690083,0,0,153.6,740.2218192098322,SRP54
28,GO_Biological_Process_2018,neurotrophin signaling pathway (GO:0038179),1/17,0.0227126314766075,0.0857218671859058,0,0,47.97355769230769,181.5719549673859,MAGI2
29,GO_Biological_Process_2018,purine-containing compound metabolic process (GO:0072521),1/17,0.0227126314766075,0.0857218671859058,0,0,47.97355769230769,181.5719549673859,MACROD1
30,GO_Biological_Process_2018,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.0227126314766075,0.0857218671859058,0,0,47.97355769230769,181.5719549673859,DLGAP5
163,GO_Biological_Process_2017b,C-terminal protein deglutamylation (GO:0035609),1/6,0.0080736268908127,0.086791489076237,0,0,153.6,740.2218192098322,AGBL4
31,GO_Biological_Process_2018,positive regulation of metabolic process (GO:0009893),1/18,0.0240330867565966,0.0878709734538063,0,0,45.14932126696833,168.33128827465845,CAMK1D
165,GO_Biological_Process_2017b,purine nucleoside metabolic process (GO:0042278),1/7,0.0094131205361766,0.0944449760463057,0,0,127.99358974358974,597.1733894173036,MACROD1
164,GO_Biological_Process_2017b,mesonephric glomerular visceral epithelial cell development (GO:0061257),1/7,0.0094131205361766,0.0944449760463057,0,0,127.99358974358974,597.1733894173036,MAGI2
34,GO_Biological_Process_2018,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.0292977495261991,0.0979381912732941,0,0,36.54212454212454,129.00263688319484,MAGI2
33,GO_Biological_Process_2018,positive regulation of phosphatase activity (GO:0010922),1/22,0.0292977495261991,0.0979381912732941,0,0,36.54212454212454,129.00263688319484,MAGI2
32,GO_Biological_Process_2018,positive regulation of receptor internalization (GO:0002092),1/21,0.0279841533165139,0.0979381912732941,0,0,38.371153846153845,137.21973105106596,MAGI2
36,GO_Biological_Process_2018,receptor clustering (GO:0043113),1/24,0.0319198157870248,0.1009356337049165,0,0,33.36120401337793,114.91361059553886,MAGI2
35,GO_Biological_Process_2018,positive regulation of neutrophil chemotaxis (GO:0090023),1/24,0.0319198157870248,0.1009356337049165,0,0,33.36120401337793,114.91361059553886,CAMK1D
37,GO_Biological_Process_2018,positive regulation of neutrophil migration (GO:1902624),1/25,0.0332282900970065,0.1023081563513095,0,0,31.96955128205128,108.83565874121032,CAMK1D
41,GO_Biological_Process_2018,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/28,0.0371435032676452,0.1034711876741545,0,0,28.413105413105413,93.56340148780022,WWOX
40,GO_Biological_Process_2018,regulation of receptor internalization (GO:0002090),1/28,0.0371435032676452,0.1034711876741545,0,0,28.413105413105413,93.56340148780022,MAGI2
39,GO_Biological_Process_2018,peptidyl-glutamic acid modification (GO:0018200),1/27,0.0358401317118484,0.1034711876741545,0,0,29.507396449704142,98.22088743474232,AGBL4
38,GO_Biological_Process_2018,positive regulation of granulocyte chemotaxis (GO:0071624),1/26,0.0345350613606546,0.1034711876741545,0,0,30.689230769230768,103.29320526635196,CAMK1D
170,GO_Biological_Process_2017b,negative regulation of nodal signaling pathway (GO:1900108),1/9,0.0120868859385031,0.1039472190711266,0,0,95.98557692307692,423.8371981703313,MAGI2
167,GO_Biological_Process_2017b,positive regulation of protein serine/threonine phosphatase activity (GO:1905184),1/9,0.0120868859385031,0.1039472190711266,0,0,95.98557692307692,423.8371981703313,MAGI2
168,GO_Biological_Process_2017b,negative regulation of activin receptor signaling pathway (GO:0032926),1/9,0.0120868859385031,0.1039472190711266,0,0,95.98557692307692,423.8371981703313,MAGI2
169,GO_Biological_Process_2017b,positive regulation of protein tyrosine phosphatase activity (GO:1903615),1/9,0.0120868859385031,0.1039472190711266,0,0,95.98557692307692,423.8371981703313,MAGI2
166,GO_Biological_Process_2017b,metanephric glomerular visceral epithelial cell development (GO:0072249),1/8,0.0107508728609495,0.1039472190711266,0,0,109.7032967032967,497.25962914000377,MAGI2
171,GO_Biological_Process_2017b,negative regulation of cell migration (GO:0030336),2/126,0.0124690343686613,0.1042549818046404,0,0,12.805806451612904,56.14714749813074,MAGI2;SRGAP3
42,GO_Biological_Process_2018,regulation of neutrophil chemotaxis (GO:0090022),1/29,0.0384451781473962,0.1043931135641315,0,0,27.396978021978025,89.27365552728025,CAMK1D
43,GO_Biological_Process_2018,regulation of leukocyte chemotaxis (GO:0002688),1/30,0.0397451584744871,0.1043931135641315,0,0,26.450928381962864,85.31131290182489,CAMK1D
44,GO_Biological_Process_2018,positive regulation of protein dephosphorylation (GO:0035307),1/31,0.0410434463585474,0.1043931135641315,0,0,25.56794871794872,81.6416333934617,MAGI2
45,GO_Biological_Process_2018,skeletal system morphogenesis (GO:0048705),1/31,0.0410434463585474,0.1043931135641315,0,0,25.56794871794872,81.6416333934617,WWOX
172,GO_Biological_Process_2017b,bone trabecula formation (GO:0060346),1/10,0.0134211618656948,0.1063543245060682,0,0,85.31623931623932,367.7917019980768,WWOX
173,GO_Biological_Process_2017b,positive regulation of dendrite extension (GO:1903861),2/131,0.0134267917981082,0.1063543245060682,0,0,12.306356589147288,53.04658921447195,CAMK1D;MAGI2
177,GO_Biological_Process_2017b,positive regulation of respiratory burst (GO:0060267),1/12,0.0160845107297618,0.1125915751083326,0,0,69.7972027972028,288.2553656873905,CAMK1D
174,GO_Biological_Process_2017b,positive regulation of myosin-light-chain-phosphatase activity (GO:0035508),1/11,0.014753702756032,0.1125915751083326,0,0,76.78076923076924,323.7277777065472,MAGI2
175,GO_Biological_Process_2017b,regulation of dendritic spine development (GO:0060998),1/12,0.0160845107297618,0.1125915751083326,0,0,69.7972027972028,288.2553656873905,CAMK1D
176,GO_Biological_Process_2017b,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.0160845107297618,0.1125915751083326,0,0,69.7972027972028,288.2553656873905,DLGAP5
178,GO_Biological_Process_2017b,nerve growth factor signaling pathway (GO:0038180),1/12,0.0160845107297618,0.1125915751083326,0,0,69.7972027972028,288.2553656873905,MAGI2
47,GO_Biological_Process_2018,negative regulation of protein kinase B signaling (GO:0051898),1/35,0.046219715818065,0.1126605573065334,0,0,22.555429864253394,69.34325924679375,MAGI2
46,GO_Biological_Process_2018,regulation of phosphoprotein phosphatase activity (GO:0043666),1/35,0.046219715818065,0.1126605573065334,0,0,22.555429864253394,69.34325924679375,MAGI2
48,GO_Biological_Process_2018,plasma membrane organization (GO:0007009),1/36,0.0475095732087328,0.1134412258249335,0,0,21.90989010989011,66.75558005419848,MYOF
49,GO_Biological_Process_2018,regulation of dendrite development (GO:0050773),1/37,0.0487977508038484,0.1141867368810054,0,0,21.30021367521368,64.32815883418561,CAMK1D
53,GO_Biological_Process_2018,regulation of phagocytosis (GO:0050764),1/41,0.0539337053893905,0.1168563616770127,0,0,19.166346153846156,55.96572434095457,CAMK1D
50,GO_Biological_Process_2018,positive regulation of phagocytosis (GO:0050766),1/39,0.0513690750681718,0.1168563616770127,0,0,20.17712550607288,59.9002146437606,CAMK1D
51,GO_Biological_Process_2018,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/40,0.0526522259283912,0.1168563616770127,0,0,19.65877712031558,57.87635915452169,DLGAP5
52,GO_Biological_Process_2018,positive regulation of receptor-mediated endocytosis (GO:0048260),1/41,0.0539337053893905,0.1168563616770127,0,0,19.166346153846156,55.96572434095457,MAGI2
179,GO_Biological_Process_2017b,glomerular visceral epithelial cell development (GO:0072015),1/13,0.0174135879176465,0.1191247718911731,0,0,63.9775641025641,259.14140891073174,MAGI2
180,GO_Biological_Process_2017b,positive regulation of granulocyte chemotaxis (GO:0071624),1/14,0.0187409364492418,0.1200217419408895,0,0,59.05325443786983,234.8574522333829,CAMK1D
182,GO_Biological_Process_2017b,mitotic G1 cell cycle arrest in response to nitrogen starvation (GO:0071851),1/14,0.0187409364492418,0.1200217419408895,0,0,59.05325443786983,234.8574522333829,MAGI2
181,GO_Biological_Process_2017b,mitotic G2 cell cycle arrest in response to glucose starvation (GO:0036227),1/14,0.0187409364492418,0.1200217419408895,0,0,59.05325443786983,234.8574522333829,MAGI2
183,GO_Biological_Process_2017b,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),1/15,0.020066558464378,0.1232660019954653,0,0,54.832417582417584,214.3235039145759,MAGI2
184,GO_Biological_Process_2017b,regulation of dendrite development (GO:0050773),1/15,0.020066558464378,0.1232660019954653,0,0,54.832417582417584,214.3235039145759,CAMK1D
54,GO_Biological_Process_2018,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.0628574380669868,0.1319117554187502,0,0,16.306055646481177,45.11699715873728,MAGI2
55,GO_Biological_Process_2018,protein heterooligomerization (GO:0051291),1/49,0.0641256214892022,0.1319117554187502,0,0,15.965544871794872,43.85593535873217,MAGI2
56,GO_Biological_Process_2018,blood circulation (GO:0008015),1/50,0.0653921522588676,0.1319117554187502,0,0,15.638932496075354,42.652889831563165,MYOF
57,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0653921522588676,0.1319117554187502,0,0,15.638932496075354,42.652889831563165,MYOF
58,GO_Biological_Process_2018,regulation of cell migration (GO:0030334),2/316,0.0674241350053821,0.1337054880615205,0,0,5.008662420382166,13.507121596701747,MAGI2;SRGAP3
185,GO_Biological_Process_2017b,regulation of dendrite morphogenesis (GO:0048814),1/17,0.0227126314766075,0.1340490602835072,0,0,47.97355769230769,181.5719549673859,CAMK1D
186,GO_Biological_Process_2017b,neurotransmitter-gated ion channel clustering (GO:0072578),1/17,0.0227126314766075,0.1340490602835072,0,0,47.97355769230769,181.5719549673859,MAGI2
59,GO_Biological_Process_2018,Notch signaling pathway (GO:0007219),1/55,0.0717000886591322,0.1398151728853078,0,0,14.187321937321938,37.38732875362038,DLGAP5
240,GO_Biological_Process_2017b,monocyte migration into blood stream (GO:0035703),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,MYOF
239,GO_Biological_Process_2017b,positive regulation of phagocytosis (GO:0050766),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,CAMK1D
243,GO_Biological_Process_2017b,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,SRP54
241,GO_Biological_Process_2017b,gastric mucosal blood circulation (GO:1990768),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,MYOF
229,GO_Biological_Process_2017b,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054),1/35,0.046219715818065,0.1431675147733306,0,0,22.555429864253394,69.34325924679375,WWOX
230,GO_Biological_Process_2017b,adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),1/36,0.0475095732087328,0.1431675147733306,0,0,21.90989010989011,66.75558005419848,HTR1E
231,GO_Biological_Process_2017b,adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881),1/36,0.0475095732087328,0.1431675147733306,0,0,21.90989010989011,66.75558005419848,HTR1E
232,GO_Biological_Process_2017b,protein heterotrimerization (GO:0070208),1/36,0.0475095732087328,0.1431675147733306,0,0,21.90989010989011,66.75558005419848,MAGI2
233,GO_Biological_Process_2017b,negative regulation of non-canonical Wnt signaling pathway (GO:2000051),1/37,0.0487977508038484,0.1431675147733306,0,0,21.30021367521368,64.32815883418561,WWOX
234,GO_Biological_Process_2017b,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/37,0.0487977508038484,0.1431675147733306,0,0,21.30021367521368,64.32815883418561,WWOX
235,GO_Biological_Process_2017b,androgen metabolic process (GO:0008209),1/37,0.0487977508038484,0.1431675147733306,0,0,21.30021367521368,64.32815883418561,WWOX
236,GO_Biological_Process_2017b,blood circulation (GO:0008015),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,MYOF
237,GO_Biological_Process_2017b,bile acid metabolic process (GO:0008206),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,WWOX
242,GO_Biological_Process_2017b,steroid catabolic process (GO:0006706),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,WWOX
238,GO_Biological_Process_2017b,vitamin D metabolic process (GO:0042359),1/39,0.0513690750681718,0.1431675147733306,0,0,20.17712550607288,59.9002146437606,WWOX
226,GO_Biological_Process_2017b,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/35,0.046219715818065,0.1431675147733306,0,0,22.555429864253394,69.34325924679375,MAGI2
187,GO_Biological_Process_2017b,positive regulation of G-protein coupled receptor internalization (GO:1904022),1/19,0.0253518240632961,0.1431675147733306,0,0,42.638888888888886,156.69384876205734,MAGI2
209,GO_Biological_Process_2017b,cellular response to nerve growth factor stimulus (GO:1990090),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,MAGI2
210,GO_Biological_Process_2017b,phytosteroid metabolic process (GO:0016128),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
211,GO_Biological_Process_2017b,steroid esterification (GO:0034433),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
212,GO_Biological_Process_2017b,ergosteryl 3-beta-D-glucoside metabolic process (GO:1904461),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
213,GO_Biological_Process_2017b,steroid acetylation (GO:0034207),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
214,GO_Biological_Process_2017b,steroid metabolic process (GO:0008202),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
215,GO_Biological_Process_2017b,(25S)-Delta(4)-dafachronate metabolic process (GO:1902057),1/33,0.0436349532899167,0.1431675147733306,0,0,23.96754807692308,75.0638863791398,WWOX
208,GO_Biological_Process_2017b,deactivation of mitotic spindle assembly checkpoint (GO:1902426),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,DLGAP5
216,GO_Biological_Process_2017b,C21-steroid hormone metabolic process (GO:0008207),1/33,0.0436349532899167,0.1431675147733306,0,0,23.96754807692308,75.0638863791398,WWOX
219,GO_Biological_Process_2017b,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,WWOX
228,GO_Biological_Process_2017b,estrogen metabolic process (GO:0008210),1/35,0.046219715818065,0.1431675147733306,0,0,22.555429864253394,69.34325924679375,WWOX
221,GO_Biological_Process_2017b,bone morphogenesis (GO:0060349),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,WWOX
222,GO_Biological_Process_2017b,adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,HTR1E
223,GO_Biological_Process_2017b,negative regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905425),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,WWOX
224,GO_Biological_Process_2017b,purine nucleoside interconversion (GO:0019686),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,MACROD1
225,GO_Biological_Process_2017b,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,WWOX
217,GO_Biological_Process_2017b,(25S)-Delta(7)-dafachronate metabolic process (GO:1902056),1/33,0.0436349532899167,0.1431675147733306,0,0,23.96754807692308,75.0638863791398,WWOX
207,GO_Biological_Process_2017b,ecdysteroid metabolic process (GO:0045455),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
206,GO_Biological_Process_2017b,mitotic cell cycle arrest (GO:0071850),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,MAGI2
205,GO_Biological_Process_2017b,steroid deacetylation (GO:0034208),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
188,GO_Biological_Process_2017b,positive regulation of macrophage chemotaxis (GO:0010759),1/20,0.0266688455361458,0.1431675147733306,0,0,40.392712550607285,146.39366123411943,CAMK1D
189,GO_Biological_Process_2017b,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction (GO:0052522),1/21,0.0279841533165139,0.1431675147733306,0,0,38.371153846153845,137.21973105106596,CAMK1D
190,GO_Biological_Process_2017b,mitotic chromosome movement towards spindle pole (GO:0007079),1/22,0.0292977495261991,0.1431675147733306,0,0,36.54212454212454,129.00263688319484,DLGAP5
191,GO_Biological_Process_2017b,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451),1/22,0.0292977495261991,0.1431675147733306,0,0,36.54212454212454,129.00263688319484,CAMK1D
192,GO_Biological_Process_2017b,neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118),1/23,0.0306096363049701,0.1431675147733306,0,0,34.87937062937063,121.60484715637172,MAGI2
193,GO_Biological_Process_2017b,positive regulation of opsonization (GO:1903028),1/24,0.0319198157870248,0.1431675147733306,0,0,33.36120401337793,114.91361059553886,CAMK1D
194,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0332282900970065,0.1431675147733306,0,0,31.96955128205128,108.83565874121032,MAGI2
195,GO_Biological_Process_2017b,"positive regulation of phagocytosis, engulfment (GO:0060100)",1/25,0.0332282900970065,0.1431675147733306,0,0,31.96955128205128,108.83565874121032,CAMK1D
196,GO_Biological_Process_2017b,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241),1/25,0.0332282900970065,0.1431675147733306,0,0,31.96955128205128,108.83565874121032,WWOX
197,GO_Biological_Process_2017b,positive regulation of neutrophil chemotaxis (GO:0090023),1/27,0.0358401317118484,0.1431675147733306,0,0,29.507396449704142,98.22088743474232,CAMK1D
198,GO_Biological_Process_2017b,receptor clustering (GO:0043113),1/28,0.0371435032676452,0.1431675147733306,0,0,28.413105413105413,93.56340148780022,MAGI2
199,GO_Biological_Process_2017b,positive regulation of apoptotic cell clearance (GO:2000427),1/28,0.0371435032676452,0.1431675147733306,0,0,28.413105413105413,93.56340148780022,CAMK1D
200,GO_Biological_Process_2017b,protein targeting to ER (GO:0045047),1/30,0.0397451584744871,0.1431675147733306,0,0,26.450928381962864,85.31131290182489,SRP54
201,GO_Biological_Process_2017b,embryonic skeletal system morphogenesis (GO:0048704),1/30,0.0397451584744871,0.1431675147733306,0,0,26.450928381962864,85.31131290182489,WWOX
202,GO_Biological_Process_2017b,mineralocorticoid metabolic process (GO:0008212),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
203,GO_Biological_Process_2017b,glucocorticoid metabolic process (GO:0008211),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,WWOX
204,GO_Biological_Process_2017b,skeletal muscle acetylcholine-gated channel clustering (GO:0071340),1/31,0.0410434463585474,0.1431675147733306,0,0,25.56794871794872,81.6416333934617,MAGI2
227,GO_Biological_Process_2017b,negative regulation of Wnt signaling pathway involved in heart development (GO:0003308),1/35,0.046219715818065,0.1431675147733306,0,0,22.555429864253394,69.34325924679375,WWOX
220,GO_Biological_Process_2017b,negative regulation of Wnt signaling pathway by Wnt receptor internalization (GO:0038012),1/34,0.0449281765490304,0.1431675147733306,0,0,23.24009324009324,72.10680817166444,WWOX
218,GO_Biological_Process_2017b,negative regulation of protein kinase B signaling (GO:0051898),1/33,0.0436349532899167,0.1431675147733306,0,0,23.96754807692308,75.0638863791398,MAGI2
244,GO_Biological_Process_2017b,negative regulation of dendrite development (GO:2000171),1/40,0.0526522259283912,0.1453974312334473,0,0,19.65877712031558,57.87635915452169,CAMK1D
60,GO_Biological_Process_2018,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/59,0.076716900477825,0.1471455304246808,0,0,13.206233421750664,33.90876403657074,WWOX
132,WikiPathways_2019_Human,Pathways Affected in Adenoid Cystic Carcinoma WP3651,1/65,0.0841931969958912,0.1473380947428097,0,0,11.96454326923077,29.607951196009186,MAGI2
131,WikiPathways_2019_Human,Hepatitis C and Hepatocellular Carcinoma WP3646,1/49,0.0641256214892022,0.1473380947428097,0,0,15.965544871794872,43.85593535873217,MYOF
130,WikiPathways_2019_Human,Aryl Hydrocarbon Receptor Pathway WP2873,1/46,0.0603161049564981,0.1473380947428097,0,0,17.032478632478632,47.829859287186046,MYOF
129,WikiPathways_2019_Human,Monoamine GPCRs WP58,1/33,0.0436349532899167,0.1473380947428097,0,0,23.96754807692308,75.0638863791398,HTR1E
62,GO_Biological_Process_2018,positive regulation of endocytosis (GO:0045807),1/64,0.08295120902835,0.1540522453383644,0,0,12.155067155067156,30.260072343994267,CAMK1D
61,GO_Biological_Process_2018,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),1/63,0.0817075991872228,0.1540522453383644,0,0,12.351736972704714,30.936262547654483,HTR1E
248,GO_Biological_Process_2017b,Wnt receptor catabolic process (GO:0038018),1/45,0.059042951121717,0.1545385068490158,0,0,17.420454545454547,49.29100393195118,WWOX
245,GO_Biological_Process_2017b,regulation of blood vessel size (GO:0050880),1/43,0.0564916585091406,0.1545385068490158,0,0,18.251831501831504,52.44959988716816,MYOF
246,GO_Biological_Process_2017b,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/44,0.0577681363361376,0.1545385068490158,0,0,17.826475849731665,50.82895021500038,HTR1E
247,GO_Biological_Process_2017b,positive regulation of receptor internalization (GO:0002092),1/45,0.059042951121717,0.1545385068490158,0,0,17.420454545454547,49.29100393195118,MAGI2
249,GO_Biological_Process_2017b,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/45,0.059042951121717,0.1545385068490158,0,0,17.420454545454547,49.29100393195118,HTR1E
250,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.059042951121717,0.1545385068490158,0,0,17.420454545454547,49.29100393195118,MYOF
252,GO_Biological_Process_2017b,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199),1/47,0.061587599908768,0.1557803997692367,0,0,16.661371237458194,46.440152226223375,HTR1E
251,GO_Biological_Process_2017b,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway (GO:0007197),1/46,0.0603161049564981,0.1557803997692367,0,0,17.032478632478632,47.829859287186046,HTR1E
254,GO_Biological_Process_2017b,adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195),1/47,0.061587599908768,0.1557803997692367,0,0,16.661371237458194,46.440152226223375,HTR1E
253,GO_Biological_Process_2017b,ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830),1/47,0.061587599908768,0.1557803997692367,0,0,16.661371237458194,46.440152226223375,MAGI2
255,GO_Biological_Process_2017b,cellular response to transforming growth factor beta stimulus (GO:0071560),1/48,0.0628574380669868,0.1576674071513587,0,0,16.306055646481177,45.11699715873728,WWOX
256,GO_Biological_Process_2017b,heart contraction (GO:0060047),1/49,0.0641256214892022,0.158211574329917,0,0,15.965544871794872,43.85593535873217,MYOF
257,GO_Biological_Process_2017b,sterol metabolic process (GO:0016125),1/49,0.0641256214892022,0.158211574329917,0,0,15.965544871794872,43.85593535873217,WWOX
63,GO_Biological_Process_2018,peptidyl-threonine phosphorylation (GO:0018107),1/68,0.0879094500534163,0.1607094633789017,0,0,11.427095292766934,27.78438766321713,CAMK1D
65,GO_Biological_Process_2018,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/77,0.0989712850798696,0.1754490962779507,0,0,10.069331983805668,23.28961492092306,MAGI2
64,GO_Biological_Process_2018,positive regulation of apoptotic signaling pathway (GO:2001235),1/76,0.0977486015575413,0.1754490962779507,0,0,10.204102564102564,23.72817506630132,WWOX
67,GO_Biological_Process_2018,mitotic sister chromatid segregation (GO:0000070),1/82,0.1050608084632341,0.1807663910323293,0,0,9.44539411206078,21.282512839552783,DLGAP5
66,GO_Biological_Process_2018,C-terminal protein amino acid modification (GO:0018410),1/82,0.1050608084632341,0.1807663910323293,0,0,9.44539411206078,21.282512839552783,AGBL4
68,GO_Biological_Process_2018,cellular response to molecule of bacterial origin (GO:0071219),1/84,0.1074855044212984,0.1822580292361147,0,0,9.216867469879515,20.55729459723843,NUGGC
71,GO_Biological_Process_2018,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/89,0.1135196000843595,0.1844693501370843,0,0,8.690996503496503,18.909694364771376,SRP54
70,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),1/89,0.1135196000843595,0.1844693501370843,0,0,8.690996503496503,18.909694364771376,CAMK1D
69,GO_Biological_Process_2018,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/88,0.1123159323620213,0.1844693501370843,0,0,8.791335101679929,19.221722799537645,MAGI2
72,GO_Biological_Process_2018,cellular response to lipopolysaccharide (GO:0071222),1/91,0.1159222222375367,0.1845769741181596,0,0,8.497008547008546,18.309658301022694,NUGGC
74,GO_Biological_Process_2018,cotranslational protein targeting to membrane (GO:0006613),1/93,0.1183185731526664,0.1845769741181596,0,0,8.311454849498327,17.739757453868066,SRP54
73,GO_Biological_Process_2018,positive regulation of cellular metabolic process (GO:0031325),1/92,0.1171211806065414,0.1845769741181596,0,0,8.403212172442942,18.021076299478864,MAGI2
258,GO_Biological_Process_2017b,steroid biosynthetic process (GO:0006694),1/58,0.0754651507447108,0.1846748810907152,0,0,13.43859649122807,34.726466325654,WWOX
263,GO_Biological_Process_2017b,positive regulation of respiratory burst involved in inflammatory response (GO:0060265),1/61,0.0792155057834973,0.1862802128190055,0,0,12.76474358974359,32.366069643921364,CAMK1D
260,GO_Biological_Process_2017b,enzyme active site formation via O-phospho-L-threonine (GO:0018333),1/61,0.0792155057834973,0.1862802128190055,0,0,12.76474358974359,32.366069643921364,CAMK1D
261,GO_Biological_Process_2017b,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125),1/61,0.0792155057834973,0.1862802128190055,0,0,12.76474358974359,32.366069643921364,CAMK1D
262,GO_Biological_Process_2017b,peptidyl-threonine trans-autophosphorylation (GO:1990294),1/61,0.0792155057834973,0.1862802128190055,0,0,12.76474358974359,32.366069643921364,CAMK1D
259,GO_Biological_Process_2017b,negative regulation of Wnt signaling pathway (GO:0030178),1/60,0.0779670181418841,0.1862802128190055,0,0,12.98174706649283,33.12253021761694,WWOX
264,GO_Biological_Process_2017b,protein heterotetramerization (GO:0051290),1/62,0.0804623654600622,0.1877455194068119,0,0,12.554854981084487,31.63780409264908,MAGI2
75,GO_Biological_Process_2018,protein targeting to ER (GO:0045047),1/97,0.1230925242003742,0.1894977017295235,0,0,7.963541666666667,16.68217820842729,SRP54
77,GO_Biological_Process_2018,cellular response to transforming growth factor beta stimulus (GO:0071560),1/100,0.1266566423028266,0.1899849634542399,0,0,7.721056721056721,15.953830010816358,WWOX
76,GO_Biological_Process_2018,steroid metabolic process (GO:0008202),1/99,0.1254701557147521,0.1899849634542399,0,0,7.800235478806908,16.19085012410627,WWOX
265,GO_Biological_Process_2017b,histone-threonine phosphorylation (GO:0035405),1/67,0.0866723154837573,0.2006797458508536,0,0,11.60081585081585,28.37119607885258,CAMK1D
266,GO_Biological_Process_2017b,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),1/68,0.0879094500534163,0.2019904157715902,0,0,11.427095292766934,27.78438766321713,HTR1E
78,GO_Biological_Process_2018,regulation of Wnt signaling pathway (GO:0030111),1/109,0.1372654968642573,0.2032919383939,0,0,7.074430199430199,14.048674406808203,WWOX
79,GO_Biological_Process_2018,peptidyl-lysine modification (GO:0018205),1/115,0.1442690063121821,0.2109934217315663,0,0,6.700067476383266,12.971837311762831,NUGGC
133,WikiPathways_2019_Human,mRNA Processing WP411,1/126,0.1569668370758771,0.2197535719062279,0,0,6.107076923076924,11.308600906176348,SRP54
80,GO_Biological_Process_2018,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/125,0.1558200282226172,0.225073374099336,0,0,6.156637717121588,11.445519530111168,HTR1E
267,GO_Biological_Process_2017b,protein heterooligomerization (GO:0051291),1/77,0.0989712850798696,0.2256845212806117,0,0,10.069331983805668,23.28961492092306,MAGI2
82,GO_Biological_Process_2018,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/134,0.1660874554738545,0.2341232806077227,0,0,5.73742047426258,10.300051259919034,HTR1E
81,GO_Biological_Process_2018,protein targeting (GO:0006605),1/133,0.1649525962977769,0.2341232806077227,0,0,5.781177156177156,10.418242827789005,SRP54
268,GO_Biological_Process_2017b,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/81,0.1038460830238891,0.2350200826330123,0,0,9.563942307692308,21.66085119098212,HTR1E
83,GO_Biological_Process_2018,muscle contraction (GO:0006936),1/137,0.169483128938328,0.2360657867355283,0,0,5.610011312217194,9.957780689975772,MYOF
84,GO_Biological_Process_2018,regulation of small GTPase mediated signal transduction (GO:0051056),1/140,0.1728654854017687,0.2379442563765522,0,0,5.488101826231323,9.63294423505462,SRGAP3
87,GO_Biological_Process_2018,skeletal system development (GO:0001501),1/146,0.1795904480842388,0.2387736639301811,0,0,5.259416445623343,9.030819377495549,WWOX
85,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.1773546654788057,0.2387736639301811,0,0,5.3335126412049485,9.22486368618758,SRP54
86,GO_Biological_Process_2018,peptidyl-serine phosphorylation (GO:0018105),1/145,0.1784732891934543,0.2387736639301811,0,0,5.296207264957265,9.127040463230198,CAMK1D
269,GO_Biological_Process_2017b,muscle contraction (GO:0006936),1/85,0.108695478928664,0.2441592474442379,0,0,9.106684981684982,20.20960155430532,MYOF
270,GO_Biological_Process_2017b,protein de-ADP-ribosylation (GO:0051725),1/86,0.1099038737594078,0.24504493334505,0,0,8.999095022624434,19.871344206358376,MACROD1
271,GO_Biological_Process_2017b,planar cell polarity pathway involved in axis elongation (GO:0003402),1/87,0.1111106909148682,0.2459141026865834,0,0,8.894007155635062,19.54216474848468,MAGI2
272,GO_Biological_Process_2017b,"SRP-dependent cotranslational protein targeting to membrane, docking (GO:0006615)",1/88,0.1123159323620213,0.2467671214669229,0,0,8.791335101679929,19.221722799537645,SRP54
88,GO_Biological_Process_2018,response to lipopolysaccharide (GO:0032496),1/155,0.1895792643766286,0.2492221790119725,0,0,4.9498001998002,8.231260640854018,NUGGC
89,GO_Biological_Process_2018,protein localization to membrane (GO:0072657),1/160,0.1950778943387402,0.2522228154396396,0,0,4.792936623125303,7.833366366967883,MAGI2
90,GO_Biological_Process_2018,negative regulation of intracellular signal transduction (GO:1902532),1/161,0.1961733008974975,0.2522228154396396,0,0,4.762740384615385,7.757345893634735,MAGI2
91,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.198359809064203,0.2522619310925191,0,0,4.70346628679962,7.608668913145152,MAGI2
273,GO_Biological_Process_2017b,"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",1/92,0.1171211806065414,0.2554599663954273,0,0,8.403212172442942,18.021076299478864,SRP54
92,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),1/170,0.205967575325258,0.2591204979898407,0,0,4.5070550751024125,7.121311633958928,CAMK1D
274,GO_Biological_Process_2017b,smooth muscle contraction (GO:0006939),1/95,0.1207086685804017,0.2613907139762657,0,0,8.13379705400982,17.197899864655323,MYOF
93,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.2102836044169887,0.2617359757105072,0,0,4.401956425077812,6.863962563453386,WWOX
94,GO_Biological_Process_2018,cellular response to lipid (GO:0071396),1/178,0.2145770377385505,0.2642685622674779,0,0,4.30160799652325,6.620546601294631,NUGGC
275,GO_Biological_Process_2017b,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/100,0.1266566423028266,0.2723117809510773,0,0,7.721056721056721,15.953830010816358,SRP54
276,GO_Biological_Process_2017b,"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)",1/102,0.1290249668906648,0.2734965847471134,0,0,7.567402894135568,15.49614436945303,SRP54
277,GO_Biological_Process_2017b,striated muscle contraction (GO:0006941),1/102,0.1290249668906648,0.2734965847471134,0,0,7.567402894135568,15.49614436945303,MYOF
278,GO_Biological_Process_2017b,positive regulation of CREB transcription factor activity (GO:0032793),1/103,0.1302068087941927,0.2740716744549091,0,0,7.492835595776772,15.27512883928758,CAMK1D
279,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway (GO:0007179),1/104,0.1313871063469724,0.2746355486836022,0,0,7.419716206123973,15.059110197836317,WWOX
281,GO_Biological_Process_2017b,muscle filament sliding (GO:0030049),1/108,0.136092891948876,0.2805750717576143,0,0,7.140905823148814,14.241948234838476,MYOF
280,GO_Biological_Process_2017b,"SRP-dependent cotranslational protein targeting to membrane, signal sequence processing (GO:0006618)",1/108,0.136092891948876,0.2805750717576143,0,0,7.140905823148814,14.241948234838476,SRP54
282,GO_Biological_Process_2017b,skeletal system morphogenesis (GO:0048705),1/110,0.1384365690381021,0.2834653556494472,0,0,7.009174311926605,13.859542066692878,WWOX
126,KEGG_2019_Human,cAMP signaling pathway,1/212,0.2501748475526315,0.3002098170631577,0,0,3.6022602989427632,4.991274634727798,HTR1E
117,KEGG_2019_Human,Protein export,1/23,0.0306096363049701,0.3002098170631577,0,0,34.87937062937063,121.60484715637172,SRP54
118,KEGG_2019_Human,Glioma,1/75,0.0965243203976375,0.3002098170631577,0,0,10.342515592515593,24.18039062518233,CAMK1D
119,KEGG_2019_Human,Taste transduction,1/83,0.1062739482697551,0.3002098170631577,0,0,9.329737335834896,20.914799669740503,HTR1E
120,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.1242821169854101,0.3002098170631577,0,0,7.8810467882632835,16.43356790965512,CAMK1D
121,KEGG_2019_Human,Serotonergic synapse,1/113,0.1419406084517323,0.3002098170631577,0,0,6.820398351648351,13.315781254294896,HTR1E
122,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.1873696997105391,0.3002098170631577,0,0,5.015435222672065,8.399206979343194,CAMK1D
123,KEGG_2019_Human,Axon guidance,1/181,0.2177823526979322,0.3002098170631577,0,0,4.229273504273504,6.4465086127084605,SRGAP3
124,KEGG_2019_Human,Calcium signaling pathway,1/188,0.2252125096394463,0.3002098170631577,0,0,4.06951871657754,6.066475645009069,CAMK1D
125,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.2440078761193004,0.3002098170631577,0,0,3.708818011257036,5.231490955504914,MAGI2
96,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.2552769580979776,0.3079113824480761,0,0,3.5179843304843303,4.803477662173212,MAGI2
95,GO_Biological_Process_2018,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/215,0.253240138459512,0.3079113824480761,0,0,3.551222142343638,4.877309132932216,CAMK1D
283,GO_Biological_Process_2017b,modulation by symbiont of host small GTPase mediated signal transduction (GO:0044082),1/129,0.1603982694288782,0.3262153993114348,0,0,5.963040865384615,10.912933494989383,SRGAP3
284,GO_Biological_Process_2017b,regulation of small GTPase mediated signal transduction (GO:0051056),1/130,0.1615390884057056,0.3263306416786402,0,0,5.916517590936196,10.785859682184276,SRGAP3
286,GO_Biological_Process_2017b,enzyme active site formation via O-phospho-L-serine (GO:0018331),1/134,0.1660874554738545,0.3267472163243805,0,0,5.73742047426258,10.300051259919034,CAMK1D
287,GO_Biological_Process_2017b,regulation of Ras protein signal transduction (GO:0046578),1/134,0.1660874554738545,0.3267472163243805,0,0,5.73742047426258,10.300051259919034,SRGAP3
285,GO_Biological_Process_2017b,negative regulation of small GTPase mediated signal transduction (GO:0051058),1/132,0.1638162499685203,0.3267472163243805,0,0,5.825601879036993,10.538571509493655,SRGAP3
288,GO_Biological_Process_2017b,histone H2A SQE motif phosphorylation (GO:1990853),1/134,0.1660874554738545,0.3267472163243805,0,0,5.73742047426258,10.300051259919034,CAMK1D
289,GO_Biological_Process_2017b,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/136,0.1683527199329199,0.3290530435052525,0,0,5.651851851851852,10.06987040383735,SRGAP3
290,GO_Biological_Process_2017b,serine phosphorylation of STAT protein (GO:0042501),1/138,0.1706120582802028,0.3313176099505875,0,0,5.568781583380123,9.847627111259085,CAMK1D
97,GO_Biological_Process_2018,anterograde trans-synaptic signaling (GO:0098916),1/240,0.2783192114594731,0.3322790585791669,0,0,3.1757322175732217,4.061718892262195,HTR1E
291,GO_Biological_Process_2017b,histone-serine phosphorylation (GO:0035404),1/140,0.1728654854017687,0.3335417378585409,0,0,5.488101826231323,9.63294423505462,CAMK1D
134,WikiPathways_2019_Human,"GPCRs, Class A Rhodopsin-like WP455",1/257,0.2949075680993878,0.3440588294492858,0,0,2.9622896634615383,3.617232061353747,HTR1E
135,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.3523502623991687,0.3523502623991687,0,0,2.377237542331882,2.479766690923064,MYOF
99,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),1/276,0.313012980149018,0.3662251867743511,0,0,2.7549650349650348,3.199921143573739,MAGI2
98,GO_Biological_Process_2018,cellular response to oxygen-containing compound (GO:1901701),1/274,0.3111284374032637,0.3662251867743511,0,0,2.775429698506622,3.2404514736591987,NUGGC
101,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.3195698620513116,0.3665654300000339,0,0,2.6856246590289143,3.063705202554494,WWOX
100,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/848,0.3184669016243092,0.3665654300000339,0,0,1.8086997635933808,2.06958070108675,WWOX;DLGAP5
102,GO_Biological_Process_2018,chemical synaptic transmission (GO:0007268),1/289,0.3251420442493717,0.3693361085162766,0,0,2.6288728632478637,2.953520609142245,HTR1E
128,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.3827589030698481,0.3827589030698481,0,0,2.1377206363042056,2.0529599786967845,MAGI2
127,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.3690324230198293,0.3827589030698481,0,0,2.241040858251541,2.234028129416312,HTR1E
103,GO_Biological_Process_2018,cellular response to DNA damage stimulus (GO:0006974),1/329,0.3611825909110406,0.4063304147749206,0,0,2.30358818011257,2.3459089109247486,MACROD1
297,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248),1/183,0.219912227286928,0.4086023482306503,0,0,4.182375316990702,6.334319417895495,MACROD1
296,GO_Biological_Process_2017b,SOS response (GO:0009432),1/182,0.2188479890204281,0.4086023482306503,0,0,4.20569485762856,6.390039838641086,MACROD1
293,GO_Biological_Process_2017b,peptidyl-threonine autophosphorylation (GO:1990443),1/181,0.2177823526979322,0.4086023482306503,0,0,4.229273504273504,6.4465086127084605,CAMK1D
292,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/179,0.2156468788043841,0.4086023482306503,0,0,4.277225583405358,6.561747497292318,WWOX
295,GO_Biological_Process_2017b,cellular response to DNA damage stimulus (GO:0006974),1/182,0.2188479890204281,0.4086023482306503,0,0,4.20569485762856,6.390039838641086,MACROD1
294,GO_Biological_Process_2017b,histone H3-K56 acetylation in response to DNA damage (GO:0097044),1/182,0.2188479890204281,0.4086023482306503,0,0,4.20569485762856,6.390039838641086,MACROD1
298,GO_Biological_Process_2017b,signal transduction in response to DNA damage (GO:0042770),1/188,0.2252125096394463,0.4158832233219223,0,0,4.06951871657754,6.066475645009069,MACROD1
299,GO_Biological_Process_2017b,DNA damage checkpoint (GO:0000077),1/197,0.2346657520091249,0.43069750826065,0,0,3.880886970172684,5.62570700950055,MACROD1
104,GO_Biological_Process_2018,negative regulation of cell proliferation (GO:0008285),1/363,0.3903532041440459,0.4349649989033654,0,0,2.0836166595835106,1.960065063567268,MAGI2
300,GO_Biological_Process_2017b,telomere maintenance in response to DNA damage (GO:0043247),1/207,0.2450390854869364,0.4470106953428356,0,0,3.6906273338312174,5.190267797314781,MACROD1
301,GO_Biological_Process_2017b,histone H4 acetylation involved in response to DNA damage stimulus (GO:2000776),1/209,0.2470974421170488,0.4480501811881427,0,0,3.654770710059172,5.109269010980882,MACROD1
302,GO_Biological_Process_2017b,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/213,0.2511979549659611,0.4527579906871514,0,0,3.585087082728592,4.952847943954335,MACROD1
105,GO_Biological_Process_2018,negative regulation of programmed cell death (GO:0043069),1/408,0.4269947999793887,0.4713055811093253,0,0,1.848988848988849,1.5734588983747515,NUGGC
106,GO_Biological_Process_2018,regulation of intracellular signal transduction (GO:1902531),1/422,0.4379552232567644,0.4788856179536583,0,0,1.786223277909739,1.4747748933179785,SRGAP3
303,GO_Biological_Process_2017b,peptidyl-serine autophosphorylation (GO:0036289),1/240,0.2783192114594731,0.4986552538648893,0,0,3.1757322175732217,4.061718892262195,CAMK1D
313,GO_Biological_Process_2017b,negative regulation of cell proliferation involved in compound eye morphogenesis (GO:2000496),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
314,GO_Biological_Process_2017b,negative regulation of leukocyte proliferation (GO:0070664),1/283,0.3195698620513116,0.5082767657122341,0,0,2.6856246590289143,3.063705202554494,MAGI2
315,GO_Biological_Process_2017b,negative regulation of hemocyte proliferation (GO:0035207),1/283,0.3195698620513116,0.5082767657122341,0,0,2.6856246590289143,3.063705202554494,MAGI2
316,GO_Biological_Process_2017b,negative regulation of cell proliferation involved in kidney development (GO:1901723),1/283,0.3195698620513116,0.5082767657122341,0,0,2.6856246590289143,3.063705202554494,MAGI2
317,GO_Biological_Process_2017b,negative regulation of trophectodermal cell proliferation (GO:1904074),1/284,0.3205016257639667,0.5082767657122341,0,0,2.675998912748029,3.0449333436587587,MAGI2
318,GO_Biological_Process_2017b,negative regulation of mesenchymal cell proliferation (GO:0072201),1/284,0.3205016257639667,0.5082767657122341,0,0,2.675998912748029,3.0449333436587587,MAGI2
319,GO_Biological_Process_2017b,negative regulation of glial cell proliferation (GO:0060253),1/284,0.3205016257639667,0.5082767657122341,0,0,2.675998912748029,3.0449333436587587,MAGI2
321,GO_Biological_Process_2017b,negative regulation of chorionic trophoblast cell proliferation (GO:1901383),1/285,0.3214321606858473,0.5082767657122341,0,0,2.6664409534127844,3.0263271993684016,MAGI2
322,GO_Biological_Process_2017b,negative regulation of myoblast proliferation (GO:2000818),1/285,0.3214321606858473,0.5082767657122341,0,0,2.6664409534127844,3.0263271993684016,MAGI2
323,GO_Biological_Process_2017b,negative regulation of cardiac muscle cell proliferation (GO:0060044),1/287,0.3232895506336487,0.5082767657122341,0,0,2.647525551371705,2.9896041621888365,MAGI2
324,GO_Biological_Process_2017b,negative regulation of fat cell proliferation (GO:0070345),1/287,0.3232895506336487,0.5082767657122341,0,0,2.647525551371705,2.9896041621888365,MAGI2
325,GO_Biological_Process_2017b,negative regulation of growth plate cartilage chondrocyte proliferation (GO:0061914),1/287,0.3232895506336487,0.5082767657122341,0,0,2.647525551371705,2.9896041621888365,MAGI2
326,GO_Biological_Process_2017b,negative regulation of neural precursor cell proliferation (GO:2000178),1/288,0.3242164086935181,0.5082767657122341,0,0,2.638166711337443,2.9714833995606664,MAGI2
327,GO_Biological_Process_2017b,negative regulation of stem cell proliferation (GO:2000647),1/288,0.3242164086935181,0.5082767657122341,0,0,2.638166711337443,2.9714833995606664,MAGI2
312,GO_Biological_Process_2017b,negative regulation of synoviocyte proliferation (GO:1901646),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
311,GO_Biological_Process_2017b,negative regulation of cell proliferation in bone marrow (GO:1903769),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
320,GO_Biological_Process_2017b,negative regulation of chondrocyte proliferation (GO:1902731),1/285,0.3214321606858473,0.5082767657122341,0,0,2.6664409534127844,3.0263271993684016,MAGI2
309,GO_Biological_Process_2017b,negative regulation of hair follicle cell proliferation (GO:0071337),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
308,GO_Biological_Process_2017b,negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
307,GO_Biological_Process_2017b,negative regulation of mammary stem cell proliferation (GO:2000102),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
306,GO_Biological_Process_2017b,negative regulation of germ cell proliferation (GO:1905937),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
305,GO_Biological_Process_2017b,negative regulation of sebum secreting cell proliferation (GO:1904003),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
304,GO_Biological_Process_2017b,DNA repair (GO:0006281),1/279,0.315830488654146,0.5082767657122341,0,0,2.724820143884892,3.1404904694524363,MACROD1
310,GO_Biological_Process_2017b,negative regulation of skeletal muscle cell proliferation (GO:0014859),1/282,0.3186368680777314,0.5082767657122341,0,0,2.695318915959485,3.0826447861539403,MAGI2
328,GO_Biological_Process_2017b,negative regulation of osteoblast proliferation (GO:0033689),1/290,0.3260664588351931,0.5085285187015187,0,0,2.619643332446101,2.9357139282276736,MAGI2
329,GO_Biological_Process_2017b,negative regulation of fibroblast proliferation (GO:0048147),1/294,0.3297519384172611,0.5116254302247196,0,0,2.5833552113415594,2.8660120115873258,MAGI2
107,GO_Biological_Process_2018,protein phosphorylation (GO:0006468),1/470,0.4740219295053918,0.5135237569641744,0,0,1.5994751517139576,1.1940109095902935,CAMK1D
331,GO_Biological_Process_2017b,negative regulation of smooth muscle cell proliferation (GO:0048662),1/303,0.3379734422987403,0.5190306435302083,0,0,2.5052215995924607,2.7176342275350884,MAGI2
330,GO_Biological_Process_2017b,negative regulation of epithelial cell proliferation (GO:0050680),1/302,0.3370647600716259,0.5190306435302083,0,0,2.5136723741374905,2.733568937937984,MAGI2
108,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.4848281964565881,0.5204119172974386,0,0,1.5487126509853784,1.1212070715369375,NUGGC
332,GO_Biological_Process_2017b,peptidyl-threonine phosphorylation (GO:0018107),1/320,0.3532387596140118,0.5397201352478048,0,0,2.36966481794068,2.465899460320656,CAMK1D
109,GO_Biological_Process_2018,negative regulation of cellular process (GO:0048523),1/534,0.5186589680499691,0.5516645387440581,0,0,1.4027998268148365,0.920950299238294,MAGI2
110,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.5389460695417463,0.5680782895169758,0,0,1.323581560283688,0.8181584007046128,WWOX
333,GO_Biological_Process_2017b,peptidyl-serine phosphorylation (GO:0018105),1/352,0.3810589518298931,0.5792865883878678,0,0,2.15012053473592,2.0744388432730063,CAMK1D
375,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.4897976505957198,0.6142878867887986,0,0,1.5260849130502898,1.089262840701213,WWOX
354,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
355,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
356,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
357,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
358,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
359,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
360,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
361,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.482684191394631,0.6142878867887986,0,0,1.558611866304174,1.1352814856391014,WWOX
362,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.482684191394631,0.6142878867887986,0,0,1.558611866304174,1.1352814856391014,WWOX
364,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.482684191394631,0.6142878867887986,0,0,1.558611866304174,1.1352814856391014,WWOX
367,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.4841144806181662,0.6142878867887986,0,0,1.5519987259117694,1.1258724420221953,WWOX
366,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.4841144806181662,0.6142878867887986,0,0,1.5519987259117694,1.1258724420221953,WWOX
374,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),1/491,0.4890905654227396,0.6142878867887986,0,0,1.5292778649921508,1.0937511535302706,WWOX
368,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.4841144806181662,0.6142878867887986,0,0,1.5519987259117694,1.1258724420221953,WWOX
369,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.4841144806181662,0.6142878867887986,0,0,1.5519987259117694,1.1258724420221953,WWOX
370,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.4841144806181662,0.6142878867887986,0,0,1.5519987259117694,1.1258724420221953,WWOX
371,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.4848281964565881,0.6142878867887986,0,0,1.5487126509853784,1.1212070715369375,WWOX
372,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.4862527767299325,0.6142878867887986,0,0,1.5421810699588476,1.1119536869107485,WWOX
353,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
373,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.4869636435143171,0.6142878867887986,0,0,1.538935397251619,1.1073652997561434,WWOX
365,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.4833998126471668,0.6142878867887986,0,0,1.5552984360038302,1.1305638498077657,WWOX
352,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
363,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.482684191394631,0.6142878867887986,0,0,1.558611866304174,1.1352814856391014,WWOX
350,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
336,GO_Biological_Process_2017b,DNA damage induced protein phosphorylation (GO:0006975),1/470,0.4740219295053918,0.6142878867887986,0,0,1.5994751517139576,1.1940109095902935,MACROD1
337,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
338,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
339,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
351,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
340,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
341,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
342,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
343,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
344,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
345,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
346,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
347,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
348,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
349,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.4819676155387536,0.6142878867887986,0,0,1.5619391025641025,1.1400255425829633,WWOX
335,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1/413,0.430932656844107,0.6142878867887986,0,0,1.8260828976848396,1.5372028827239483,MAGI2
334,GO_Biological_Process_2017b,negative regulation of cell proliferation (GO:0008285),1/399,0.4198404364211796,0.6142878867887986,0,0,1.891669887901044,1.6417435087321954,MAGI2
376,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.4926165792755423,0.6152597110453869,0,0,1.5134421134421134,1.0715535465603052,WWOX
377,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.5186589680499691,0.6451088817481021,0,0,1.4027998268148365,0.920950299238294,WWOX
428,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),1/730,0.6338083935911003,0.6482678540360178,0,0,1.0153002004853855,0.4629856113602424,WWOX
404,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
405,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
406,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
407,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
430,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/733,0.6353455712313132,0.6482678540360178,0,0,1.010981504833964,0.4585672807362063,WWOX
408,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
409,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
410,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
411,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
412,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
413,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
414,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),1/721,0.6291593297146684,0.6482678540360178,0,0,1.0284722222222222,0.476563942883363,WWOX
415,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/722,0.6296786856451443,0.6482678540360178,0,0,1.0269924250506774,0.4750308402655041,WWOX
416,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),1/723,0.6301973412486923,0.6482678540360178,0,0,1.0255167270402727,0.4735039096641827,WWOX
417,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/724,0.6307152972509923,0.6482678540360178,0,0,1.0240451111820406,0.4719831200500293,WWOX
418,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
419,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
420,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
421,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
422,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
423,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),1/725,0.6312325545943012,0.6482678540360178,0,0,1.022577560560986,0.4704684402350005,WWOX
403,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
424,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/726,0.6317491141974947,0.6482678540360178,0,0,1.0211140583554377,0.4689598392627362,WWOX
425,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1/727,0.632264977057387,0.6482678540360178,0,0,1.019654587836406,0.4674572862432825,WWOX
426,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),1/728,0.6327801439615515,0.6482678540360178,0,0,1.0181991323669453,0.4659607508151571,WWOX
427,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),1/729,0.6332946159062058,0.6482678540360178,0,0,1.0167476754015214,0.4644702024692366,WWOX
429,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),1/731,0.6343214782031841,0.6482678540360178,0,0,1.0138566912539515,0.4615069470474737,WWOX
402,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
394,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
400,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
378,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
379,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
380,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
381,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
401,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
383,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
384,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
385,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
386,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
387,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
382,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
389,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
390,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
391,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
392,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
393,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
395,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
396,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
397,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
398,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
399,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
388,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),1/720,0.628639272281196,0.6482678540360178,0,0,1.0299561356585,0.4781032494786656,WWOX
431,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),1/739,0.638401306630133,0.6491851124853717,0,0,1.0024494475713988,0.4498874692548034,WWOX
432,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),1/744,0.6409289025897892,0.6495609416819075,0,0,0.995444663008593,0.4428103633318724,WWOX
433,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),1/756,0.6469259087190641,0.6534385856524775,0,0,0.9790117167600612,0.4263826154511068,WWOX
434,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),1/770,0.6538005438501805,0.6581737916351316,0,0,0.9604881464439332,0.4081622740210583,WWOX
111,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),1/740,0.6389081925943141,0.6674308797637032,0,0,1.0010409076714897,0.4484608294086311,MAGI2
112,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",1/813,0.6741189807247732,0.6927996095078621,0,0,0.9075881015536188,0.3579061465826397,WWOX
113,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.6750355169563784,0.6927996095078621,0,0,0.9052636552636552,0.3557595383361729,NUGGC
435,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/991,0.7466654702979465,0.7491543551989397,0,0,0.7374902874902874,0.2154489561045548,WWOX
114,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.7502416917264013,0.763289373321643,0,0,0.7297307692307692,0.2096953380542307,MACROD1
115,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.7892374393377507,0.7960412103665244,0,0,0.6480373960266722,0.1533827181893499,WWOX
436,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.8052125506702598,0.8052125506702598,0,0,0.6158760319748394,0.1334289254140564,WWOX
116,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.8743511509414755,0.8743511509414755,0,0,0.4816415811676475,0.0646715609242304,WWOX
